Document is current
Any future updates will be listed below
-
Authors
Saleh, Fawaz https://orcid.org/0009-0002-6925-5127
Valdivia Malqui, Edwin Emilio https://orcid.org/0000-0002-1602-5734
Gensch, Ingrid https://orcid.org/0009-0008-1021-1940
Schinke, Maximilian https://orcid.org/0000-0002-0442-2185
Kappelhøj, Malene
Nikolouli, Eirini
Nguyen, Ariane Hai Ha
Jang, Mi-Sun
Basílio-Queirós, Débora https://orcid.org/0000-0001-5745-0211
Lachmann, Nico https://orcid.org/0000-0002-4245-1497
- License Information
-
More Information
Article History
Received: 26 September 2024
Accepted: 21 November 2025
First Online: 18 February 2026
Competing interests
: N.L. is an author of the patent application (European patent application number PCT/EP2018/061574) entitled ‘Stem-cell derived myeloid cells, generation and use thereof’. The priority date of the application is 4 May 2017. N.L. is an author on the patent application (European patent application number PCT/EP2021/083371) entitled ‘Application of stem cell derived monocytes in a monocyte activation test for the assessment of pyrogenicity and inflammatory potential’. The priority date of the application is 29 November 2021. N.L. receives research funding from Novo Nordisk and holds a consultancy agreement with Evotec (scope outside the manuscript). All other authors declare no competing interests.
